Mode
Text Size
Log in / Sign up
Phase 4 Completed N=60 Randomized Basic Science

Comparison of Obturator Nerve Blockade and Neuromuscular Blockade

Source: ClinicalTrials.gov NCT03063255 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcomePrimary: Number of Patients With Incidence of Intraoperative Adductor Spasm — 1; 5 Participants
◆ Published Evidence
Emerging
8citations · ~2 / year
Obturator Nerve Blockade vs. Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors: A Randomized Controlled Trial.
Pain medicine (Malden, Mass.) · 2021 · Open access · Likely link

Summary

Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.

Linked Publications

  • Obturator Nerve Blockade vs. Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors: A Randomized Controlled Trial.
    Pain medicine (Malden, Mass.) · 2021 · 8 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients With Incidence of Intraoperative Adductor Spasm
1; 5
SECONDARY
Number Patients With Increased Risk of Falling
28; 29
SECONDARY
Number of Patients With Incidence of Leg Weakness
27; 22

Eligibility Criteria

Inclusion Criteria

  • Patients ≥ 18 years of age
  • Planned TURBT for unilateral or bilateral posterolateral bladder tumors
  • Ability to understand and provide informed consent

Exclusion Criteria

  • Patient refusal or inability to provide informed consent
  • True allergy, not sensitivity, to local anesthetics
  • True allergy, not sensitivity, Propofol
  • True allergy, not sensitivity, general anesthetic agents
  • Pregnancy
  • Severe hepatic impairment
  • Evidence of infection at or near the proposed needle insertion site
  • Any sensorimotor deficit of the lower extremity, whether acute or chronic
  • Inability to walk without assistance
  • Lower extremity joint replacement surgery in the preceding six months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03063255) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search